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ABSTRACT 
 
The purpose of this study is to examine the distribution of Abcg2 and Abcc2 mRNAs in the 
intestine and liver of male Wistar rats, and any regional differences. Nine-week-old male 
rats were used, and their intestine divided equally into nine segments. The expression pat-
terns of Abcg2 and Abcc2 mRNAs in the intestine and liver were examined using a reverse 
transcription-polymerase chain reaction (RT-PCR). PCR products for Abcg2 mRNA were 
readily detectable in the intestine, but no bands were detected in the liver. In addition, the 
level of Abcg2 mRNA increased significantly from the duodenum to ileum, indicating a re-
gional difference in Abcg2 mRNA expression in the intestine. This regional difference was 
comparable to that of Abcb1/mdr1a as reported previously. On the other hand, Abcc2 
mRNA was detected at a higher level in the liver than in the intestine. However, there was 
no regional difference in Abcc2 mRNA expression in the intestine. Collectively, Abcg2 was 
predominant in the intestine rather than liver in male Wistar rats, whereas Abcc2 was pre-
dominant in the liver. These findings will provide useful information for evaluating the gas-
trointestinal secretion of drugs as well as drug-drug interactions in rats. 
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INTRODUCTION 
 
The ATP-binding cassette (ABC) 
transporters represent a large family of 
transmembrane proteins that use energy 
derived from the hydrolysis of ATP to 
transport various compounds (amino acids, 
lipids, lipopolysaccharides, inorganic ions, 
peptides, saccharides, metals, drugs, and 
proteins) across extra- and intra-cellular 
membranes (Leslie et al., 2005; Takara et 
al., 2006). To date, approximately 50 
transporters have been identified in hu-
mans and divided into seven subfamilies, 
ABCA to ABCG, based on a phylogenetic 
classification (Dean et al., 2001). 
Previously, we demonstrated that 
Abcb1/mdr1a mRNA expression in-
creased gradually from the upper to lower 
intestine of male Wistar rats (Takara et al., 
2003). In addition, the mRNA of the cy-
tochrome P450 (CYP) 3A subfamily was 
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found to be distributed differently from 
that of Abcb1/mdr1a, suggesting coopera-
tion among drug clearance pathways (Ta-
kara et al., 2003, 2007). Taipalensuu et al. 
(2001) reported that the level of 
Abcg2/BCRP or Abcc2/MRP2 in normal 
human jejunum was higher than that of 
Abcb1/mdr1 (Taipalensuu et al., 2001). 
However, the distribution of Abcg2/BCRP 
in the intestine remains unclear in humans 
and experimental animals. 
The pharmacokinetics of drugs differ 
between humans and experimental ani-
mals (Feng et al., 2000; Lin, 1995). De-
tailed and systematic studies have re-
vealed marked differences among species 
in the bioavailability of many drugs (Cao 
et al., 2006; Chiou and Buehler, 2002; 
Takahashi et al., 2008). Drug transporters 
including Abcb1 and Abcg2 are known to 
contribute to the bioavailability of some 
drugs. Therefore, the distribution of 
transporters in the intestine should be 
clarified in experimental animals as well 
as humans. 
Abcg2/BCRP and Abcc2/MRP2 in 
humans are referred to as Abcg2 and 
Abcc2 in rodents, respectively. The pre-
sent study examined the distribution of 
Abcg2 and Abcc2 mRNAs in the intestine 
and liver of male Wistar rats using the 
semi-quantitative reverse transcrip-
tion-polymerase chain reaction (RT-PCR) 
technique. Regional differences were also 
examined. 
 
MATERIALS AND METHODS 
 
Animals 
Nine-week-old male Wistar rats (240 
to 250 g) were purchased from Japan SLC, 
Inc. (Hamamatsu, Japan). After an over-
night fast with free access to water, the 
rats were anesthetized with an intraperi-
toneal injection of pentobarbital sodium 
(Nembutal injection®, Dainippon Phar-
maceutical Co., Ltd., Osaka, Japan), and 
sacrificed by exsanguination via the aorta 
in the abdomen. Animal experimental 
protocols were carried out in accordance 
with the Guidelines for Animal Experi-
mentation at Kyoto Pharmaceutical Uni-
versity. 
 
Removal of tissue and extraction of RNA 
The removal of tissue from rats and 
the extraction of total RNA from the tis-
sue samples were carried out as reported 
previously (Takara et al., 2003, 2007). 
That is, the intestine was excised quickly 
after exsanguination, and rinsed in an 
ice-cold 0.9 % NaCl solution. The intes-
tine (total of ca. 90 cm) was divided into 
three parts; upper (almost corresponding 
to the duodenum, ~30 cm immediately 
distal to the pyloric valve), middle (al-
most corresponding to the jejunum, the 
30 cm between the upper and lower sites), 
and lower (almost corresponding to the 
ileum, the last 30 cm before the cecum). 
Each part was re-divided into three (about 
10 cm each), and the centers (1 cm distal) 
were cut out to obtain nine segments. 
These segments were designated S1, S2, 
S3, S4, S5, S6, S7, S8, and S9, in the di-
rection from the duodenum to ileum. For 
hepatic samples, the liver was excised 
quickly after exsanguination and cut into 
parts (3 mm squares). Tissue samples of 
both intestine and liver were collected 
from three rats, immersed quickly into 
RNAlaterTM (Sigma-Aldrich Corp., St. 
Louis, MO), and stored at –80 °C until the 
extraction of RNA. 
For the extraction of RNA, aliquots 
(3 mm squares) of the tissue samples were 
homogenized in RNAlaterTM using a pes-
tle, and total RNA was extracted using a 
GenEluteTM Mammalian Total RNA kit 
(Sigma-Aldrich) according to previous 
reports (Takara et al., 2003, 2007). 
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RT-PCR 
The RT-PCR analysis was performed 
as described (Takara et al., 2003, 2007). 
Aliquots (0.3 µg) of total RNA were used 
for reverse transcription with an RNA 
PCR kit (AMV) ver. 2.1 (TakaraBio Co., 
Ltd., Shiga, Japan). The RT reaction was 
conducted in 15 µL of RT reaction mix-
ture, which was incubated at 30 °C for 10 
min and subsequently at 42 °C for 30 min 
in a thermal cycler (iCycler Thermal Cy-
cler, Bio-Rad Laboratories, Inc., CA). The 
reaction was terminated by heating at 
99 °C for 5 min, followed by cooling at 
5 °C for 5 min in a thermal cycler 
(Bio-Rad), giving the RT product. 
PCR primer sequences for the ampli-
fication of Abcg2, Abcc2 and glyceralde-
hyde-3-phosphate dehydrogenase 
(GAPDH) are listed in Table 1 (Takara et 
al., 2003, 2007; Tavelin et al., 2003; Vos 
et al., 1998), and were synthesized by 
GeneDesign, Inc. (Osaka, Japan). The 
amplification of cDNA was performed in 
a total volume of 25 µL including 5 µL of 
RT product using an RNA PCR kit 
(AMV) ver. 2.1 (TakaraBio). After initial 
denaturation at 95 °C for 1 min, the three 
cDNAs were amplified for 22 cycles of 
30 sec at 94 °C for denaturation, 1 min at 
60 °C for annealing, and 1 min at 72 °C 
for extension, with a final extension pe-
riod of 10 min at 72 °C, using a thermal 
cycler (Bio-Rad). The PCR products were 
separated on Tris-acetate-EDTA 3 % aga-
rose gels containing 100 ng/mL ethidium 
bromide, and photographed under ultra-
violet illumination at 312 nm with a Po-
laroid camera. Band densities were meas-
ured using the computer program NIH 
Image ver. 1.63 (National Institutes of 
Health, Bethesda, MD), and the ratio of 
band density (target gene /GAPDH) was 
calculated. 
 
Statistical analysis 
Results are expressed as percentages 
of the ratio of Abcc2 or Abcg2 mRNA to 
GAPDH mRNA in the S1 region, and 
represent the mean ± S.E. for three rats. 
All results except those for the liver were 
compared with the S1 region by a 
non-repeated measures one-way analysis 
of variance followed by the Bonferroni 
test. p values of less than 0.05 (two-tailed) 
were considered significant. 
Table 1: Gene-specific oligonucleotide primers used in the PCR for detecting mRNA 
Gene  Sequence (5’ to 3’) 
Fragment 
sizea) 
Forward AGT CCG GAA AAC AGC TGA GA Abcg2 
Reverse CCC ATC ACA ACG TCA TCT TG 
234 
Forward CTG GTT GGA AAC TTG GTC GT 
Abcc2 
Reverse CAA CTG CCA CAA TGT TGG TC 
172 
Forward CGA TCC CGC TAA CAT CAA AT 
GAPDH 
Reverse GGA TGC AGG GAT GAT GTT CT 
391 
a)Area amplified refers to sequences deposited in GenBank with accession numbers 
as follows: NM181381 (Abcg2), D86086 (Abcc2) and AF106860 (GAPDH). The 
primer sequences for Abcg2 were designed by Primer3 software (Rozen and 
Skaletsky, 2000). The primer sequences for Abcc2 and GAPDH were cited from a 
previous report (Tavelin et al., 2003; Vos et al., 1998). 
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RESULTS 
 
Expression of Abcg2 and Abcc2 mRNAs in 
the intestine and liver of male rats 
Figure 1 shows representative elec-
trophoretograms of PCR products derived 
from the Abcg2 and Abcc2 mRNAs. 
Abcg2 mRNA was detected in the intes-
tine (Figure 1A), but not in the liver. 
Abcc2 mRNA was expressed strongly in 
the liver and weakly in the intestine (Fig-
ure 1B).  
 
Distribution of Abcg2 mRNA in the intes-
tine 
Regional differences in the expression 
of Abcg2 mRNA in the intestine were 
evaluated by examining the PCR products 
(234 b.p.) derived from the mRNA (Fig-
ure 2). The level of Abcg2 mRNA in-
creased gradually from the upper to lower 
intestine, with the level of expression 
markedly higher in the lower region than 
upper or middle region. 
 
Distribution of Abcc2 mRNA in the intes-
tine 
The PCR product (172 b.p.) derived 
from Abcc2 mRNA in the intestine in-
creased slightly in the direction from S1 
(the upper region) to S4 (the middle re-
gion), but subsequently decreased in the 
S5 region (Figure 3). The expression from 
S5 to S9 was almost stable, and not sig-
nificantly different from that in the S1 re-
gion. 
 
DISCUSSION 
 
In the present study, the distribution 
of Abcg2 and Abcc2 mRNAs was exam-
ined in the intestine and liver of male 
Wistar rats using the semi-quantitative 
RT-PCR technique. The findings were 
then compared with those for 
Abcb1/mdr1a (Takara et al., 2003).  
Abcg2 mRNA was observed in the 
intestine but not in the liver (Figure 1A). 
Tanaka et al. (2005) detected some Abcg2 
mRNA in the liver using the branched 
DNA hybridization assay (bDNA), but 
found that levels were higher in the intes-
tine (Tanaka et al., 2005). Therefore, 
Abcg2 was suggested to predominate in 
the intestine. In addition, the level of 
Abcg2 mRNA increased gradually from 
the upper to lower intestine (Figure 2). 
This expression profile was similar to that 
of Abcb1/mdr1a mRNA (Takara et al., 
2003), but different from the distribution 
of the cytochrome P450 (CYP) 3A family 
in the intestine of normal male rats (Ta-
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Figure 1: Expression for Abcg2 (A) and Abcc2 
(B) mRNAs in the intestine and liver of male 
Wistar rats determined by RT-PCR. Rats were 
sacrificed, and their tissues were quickly 
collected into RNA laterT M. Total RNA was 
extracted from the tissue using a GenEluteTM
Mammalian Total RNA kit. PCR products were 
separated on a 3% agarose gel stained with 
100 ng/mL ethidium bromide, to visualize the 
DNA bands. M.W., Molecular weight marker 
(100 bp DNA ladder).
In
te
st
in
e
Li
ve
r
M
.W
.
In
te
st
in
e
Li
ve
r
M
.W
.
EXCLI Journal 2009;8:12-19 – ISSN 1611-2156 
Received: January 08, 2009, accepted: January 12, 2009, published: January 13, 2009 
 
16 
kara et al., 2003, 2007). Therefore, Abcg2 
as well as Abcb1/mdr1a may cooperate 
with the CYP3A family in drug clearance. 
So, Abcg2 was considered to play an im-
portant role in the pharmacokinetics, in-
cluding intestinal absorption and 
bioavailability, of substrates for Abcg2 
drugs. 
Next, the distribution of Abcc2 
mRNA was examined in male Wistar rats. 
Abcc2 mRNA was expressed weakly in 
the intestine but strongly in the liver (Fig-
ure 1B), unlike Abcg2 mRNA (Figure 1A). 
In addition, Abcc2 mRNA levels in the 
intestine increased slightly from the upper 
to middle region, and subsequently de-
creased in the lower region (Figure 3). 
These results were supported by the find-
ings on the distribution of Abcc2 in the 
intestine of Sprague-Dawley rats (Gotoh 
et al., 2000; Mottino et al., 2000). There-
fore, the distribution of Abcc2 was sug-
gested to be different from that of Abcb1 
or Abcg2. However, enzymes which con-
tribute to phase II detoxifying reactions, 
e.g., UDP-glucuronosyltranferase, glu-
tathione S-transferases, and sulfotrans-
ferases, are known to be located in en-
terocytes. These activities were reported 
to be the greatest in the proximal portion 
with decreases observed further down the 
intestine (Clifton and Kaplowitz, 1977; 
Koster et al., 1985; Pinkus et al., 1977). 
The distribution of Abcc2 in the intestine 
was suggested to be similar to that of 
phase II detoxifying enzymes including 
glutathione S-transferase and UDP-glucu-
ronosyltransferase. Abcc2 is known to be 
responsible for the intestinal excretion of 
glutathione, glucuronide, or sulfate con-
jugated, and some non-conjugated, or-
ganic anions (Adachi et al., 2005; Chu et 
0
100
200
300
400
500
600
700
800
S1 S2 S3 S4 S5 S6 S7 S8 S9
Ab
cg
2/
G
AP
D
H 
m
R
N
A 
ex
pr
es
si
on
(%
 o
f e
xp
re
ss
io
n 
in
 S
1)
Upper        Middle        Lower
*
**
Intestine
Figure 2: Regional differences in Abcg2 mRNA 
expression in the intestine of male W istar rats 
determined by RT-PCR. Rats were sacrificed, 
and their tissues were quickly collected into 
RNAlaterTM. Total RNA was extracted from the 
tissue using a GenEluteTM Mammalian Total RNA 
kit. PCR products were separated on a 3% 
agarose gel stained with 100 ng/mL eth idium
bromide, to visualize the DNA bands. Data were 
obtained after a densitometric analysis of three 
electrophoretograms derived from three rats. 
Results are expressed as percentages of the ratio 
of Abcg2 mRNA to GAPDH mRNA in the S1 
region. Each bar represents the mean± S.E. for 
three rats. * and ** p<0.05 and 0.01 significantly 
different from S1, respectively.
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Figure 3: Regional differences in Abcc2 mRNA 
expression in the intestine of male Wistar rats 
determined by RT-PCR. Rats were sacrificed, 
and their tissues were quickly collected into 
RNA laterTM. Total RNA was extracted from the 
tissue using a GenEluteTM Mammalian Total RNA 
kit. PCR products were separated on a 3% 
agarose gel stained with 100 ng/mL ethidium
bromide, to visualize the DNA bands. Data were 
obtained after a densitometric analysis of three 
electrophoretograms derived from three rats. 
Results are expressed as percentages of the 
ratio of Abcc2 mRNA to GAPDH mRNA in the S1 
region. Each bar represents the mean± S.E. for 
three rats.
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al., 2004; Gotoh et al., 2000). Conse-
quently, Abcc2 and conjugating enzymes 
may also act together to metabolize and 
secrete xenobiotics into the intestinal lu-
men, although Abcc2 was predominantly 
distributed in the liver. 
Detailed and systematic studies have 
demonstrated marked differences among 
species in the bioavailability of many 
drugs (Cao et al., 2006; Chiou and 
Buehler, 2002; Takahashi et al., 2008). 
Understanding the relationship between 
the oral absorption and bioavailability of 
drugs in humans and experimental ani-
mals is important in drug discovery and 
development. In addition, drug transport-
ers including Abcb1, Abcc2, and Abcg2 
have been reported to contribute to the 
bioavailability of some drugs (Dietrich et 
al., 2003; Greiner et al., 1999; Marchetti 
et al., 2008). Therefore, the present find-
ings should prove useful for drug devel-
opment. 
In conclusion, Abcg2 was expressed 
predominantly in the intestine rather than 
liver, whereas Abcc2 predominated in the 
liver, in male Wistar rats. In addition, re-
gional differences in the expression of 
Abcg2 but not Abcc2 were observed in 
the intestine. 
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